MX2023008904A - Regimen de dosificacion para el tratamiento del eczema cronico de manos. - Google Patents
Regimen de dosificacion para el tratamiento del eczema cronico de manos.Info
- Publication number
- MX2023008904A MX2023008904A MX2023008904A MX2023008904A MX2023008904A MX 2023008904 A MX2023008904 A MX 2023008904A MX 2023008904 A MX2023008904 A MX 2023008904A MX 2023008904 A MX2023008904 A MX 2023008904A MX 2023008904 A MX2023008904 A MX 2023008904A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- hand eczema
- dosing regime
- chronic hand
- subject
- Prior art date
Links
- 201000004624 Dermatitis Diseases 0.000 title abstract 2
- 208000010668 atopic eczema Diseases 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title abstract 2
- IUEWXNHSKRWHDY-UHFFFAOYSA-N N-[3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide Chemical compound C1C(NS(=O)(=O)CCC)CC1N(C)C1=NC=NC2=C1C=CN2 IUEWXNHSKRWHDY-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describe un método para tratar el eczema crónico de manos de moderado a grave en un sujeto que necesite del mismo, que comprende la etapa de administrar a dicho sujeto una cantidad terapéuticamente efectiva del compuesto de N-((1S,3S)-3-(metil(7H- pirrolo[2,3-d]pirimidin-4-il)amino)ciclobutil)propano-1-sulfonami da, o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163144912P | 2021-02-02 | 2021-02-02 | |
| PCT/IB2022/050818 WO2022167913A1 (en) | 2021-02-02 | 2022-01-31 | Dosing regime for treatment of chronic hand eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023008904A true MX2023008904A (es) | 2023-08-09 |
Family
ID=80222496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023008904A MX2023008904A (es) | 2021-02-02 | 2022-01-31 | Regimen de dosificacion para el tratamiento del eczema cronico de manos. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4288058A1 (es) |
| JP (1) | JP2024505910A (es) |
| KR (1) | KR20230125813A (es) |
| CN (1) | CN116847850A (es) |
| CA (1) | CA3210150A1 (es) |
| IL (1) | IL304874A (es) |
| MX (1) | MX2023008904A (es) |
| WO (1) | WO2022167913A1 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3290421T3 (en) | 2013-02-22 | 2019-03-18 | Pfizer | COMBINATION OF PYRROLO [2, 3-D] PYRIMIDINE DERIVATIVES AND ONE OR MORE ADDITIONAL SUBSTANCES AS JANUS-RELATED KINASES (JAK) INHIBITORS |
| JP6929860B2 (ja) * | 2016-01-21 | 2021-09-01 | レオ ファーマ アクティーゼルスカブ | 手湿疹の治療 |
-
2022
- 2022-01-31 MX MX2023008904A patent/MX2023008904A/es unknown
- 2022-01-31 EP EP22703083.0A patent/EP4288058A1/en active Pending
- 2022-01-31 KR KR1020237025554A patent/KR20230125813A/ko active Search and Examination
- 2022-01-31 WO PCT/IB2022/050818 patent/WO2022167913A1/en active Application Filing
- 2022-01-31 IL IL304874A patent/IL304874A/en unknown
- 2022-01-31 CA CA3210150A patent/CA3210150A1/en active Pending
- 2022-01-31 CN CN202280012729.3A patent/CN116847850A/zh active Pending
- 2022-01-31 JP JP2023545906A patent/JP2024505910A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3210150A1 (en) | 2022-08-11 |
| IL304874A (en) | 2023-10-01 |
| JP2024505910A (ja) | 2024-02-08 |
| EP4288058A1 (en) | 2023-12-13 |
| WO2022167913A1 (en) | 2022-08-11 |
| KR20230125813A (ko) | 2023-08-29 |
| CN116847850A (zh) | 2023-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021015605A (es) | Compuestos 2,3-dihidroquinazolin como inhibidores nav1.8. | |
| JOP20220101A1 (ar) | مثبطات صغيرة الجزئ لطافر G12C لبروتين ساركوما جرذان Kirsten (KRAS) | |
| EA201070167A1 (ru) | Замещенные производные индазола, активные как ингибиторы киназы | |
| GEP20125691B (en) | Compounds and compositions as protein kinase inhibitors | |
| MX2021009199A (es) | Conjugado de farmaco de dos ligandos y uso del mismo. | |
| EA200970595A1 (ru) | Производные замещенных индазолов, активные в качестве ингибиторов киназ | |
| EA200400737A1 (ru) | Препарат аминокислот и рибофлавина, применимый для уменьшения токсического действия цитотоксической химиотерапии | |
| EA200501849A1 (ru) | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ | |
| EA200970611A1 (ru) | Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы | |
| TW200639159A (en) | Treatment of pain | |
| MY150682A (en) | Method for using vasopressin antagonist with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival | |
| NZ703152A (en) | Dosing regimen for janus kinase (jak) inhibitors | |
| AU2020278236A8 (en) | Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor | |
| JOP20210185A1 (ar) | مركبات هالو-آلِّيلامين واستخدامها | |
| IL300151A (en) | Combinations for cancer treatment | |
| MX2021015543A (es) | Derivado de pirimidina que inhibe el crecimiento de celulas cancerosas y uso medicinal del mismo. | |
| MX2023006842A (es) | Proceso de fabricacion e intermediarios para un compuesto de pirrolo[2,3-d]pirimidina y su uso. | |
| AU2018282104A1 (en) | Use of vibegron to treat overactive bladder | |
| MX2021002042A (es) | Inhibidores de arginasa y sus metodos de uso. | |
| PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
| MX2023000943A (es) | Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y metodos de uso de los mismos. | |
| MX2022012310A (es) | Metodos para tratar la esclerosis multiple recidivante con un inhibidor de tirosina quinasa de bruton. | |
| MX2021014944A (es) | Metodos para tratar cancer usando inhibidores de prmt5. | |
| MX2023008904A (es) | Regimen de dosificacion para el tratamiento del eczema cronico de manos. | |
| EA201391076A1 (ru) | Комбинации |